Indeed, maternal circulating SCFAs, in particular acetic, propionic and butyric acids, seemed to be closely related to clinical markers in GDM pregnancies and may exert favorable effects on physiological activities either directly or through GPR and HDAC, affecting the placental immunometabolism and fetal development at birth [53]. The gene discussed is HDAC9; the disease is gestational diabetes.